thechallengingrealityof schizophreniagene3cs · howmanyvariantsdoweexpecttofind(e.g.t2d)? $...

46
The challenging reality of schizophrenia gene3cs Professor Bryan Mowry, MD, FRANZCP Queensland Brain Ins3tute The University of Queensland & Director, Gene3cs Program Queensland Centre for Mental Health Research, Brisbane May 2010

Upload: others

Post on 24-Aug-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  challenging  reality  of  schizophrenia  gene3cs  

Professor  Bryan  Mowry,  MD,  FRANZCP  Queensland  Brain  Ins3tute  

The  University  of  Queensland    &  

Director,  Gene3cs  Program  Queensland  Centre  for  Mental  Health  

Research,  Brisbane  

May  2010  

Page 2: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Gene3cs  of  schizophrenia    

•  Substan(al  gene(c  component  (family,  twin,  adop(on)  

•  However,  complex  inheritance  pa>ern  (i.e.  non-­‐Mendelian)  –  Spectrum  of  disease:  Mendelian  diseases  -­‐  common  diseases    

•  Mul(ple  SZ  variants  –  common  and  rare  in  the  popula(on  –  Most  of  small/modest  effect  size  

•  Interac(ng  with  environmental/other  gene(c  factors  

•  Heterogeneity  –  allelic  –  locus      –  popula(on  –  phenotypic  

Page 3: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Most  SZ  variants  occur  frequently  and  confer  small  effects  on  risk  

SZ  gene3c  variants  

Wright,  Gen  Biol,  01  

Page 4: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

There  are  different  classes  of  gene3c  variant  

Frazer  et  al,  Nat  Rev  Genet,  09    

Vast  majority  hypothesised  to  be  neutral  

Page 5: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Recent  Molecular  Gene3c  Technological  Landmarks  

•  2001:  Two  reference  versions  of  human  genome  –  Human  Genome  Sequencing  Consor(um,  reflec(ng  assembly  of  sequences  derived  from  numerous  individuals  

–  Celera  Genomics:  consensus  sequence  derived  from  5  individuals  

•  2005-­‐07:  Interna(onal  HapMap  Project  •  2007:  Encode  Pilot  Project  •  2007:  First  complete  human  genome  sequence    

 –  J.  Craig  Venter  

•  2009:  1000  Genomes  Project    –  To  catalogue  human  varia(on  including  rare  variants  

Page 6: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Genome-­‐wide  associa3on  (GWA)  studies    •  Inves(gates  associa(on  between  common  gene(c  varia(on  and  disease  

•  Hypothesis-­‐free  -­‐  no  bias  or  presump(ve  list  of  candidate  genes  being  tested    

•  This  type  of  analysis  requires:  –   a  dense  set  of  SNP  markers  (500,000  –    >1  million)  that  capture  a  substan(al  

propor(on  of  common  varia(on  across  the  genome  –  large  numbers  of  study  par(cipants  (many  1000’s)    

•  Detects  differences  in  allele  frequencies  between  cases  and  controls  at  each  marker  

•  >80  phenotypes  (from  all  disease  categories),  GWA  studies  have  provided:  –   compelling  sta(s(cal  associa(ons  for  >650  loci  across  genome  –   new  understanding  of  molecular  underpinnings  &  pathways  of  many  diseases  

Page 7: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Published  Genome-­‐Wide  Associa3ons  through  12/2009,    658  published  GWA  at  p<5x10-­‐8  

NHGRI  GWA  Catalog  www.genome.gov/GWAStudies  

Page 8: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*
Page 9: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

MGS  GWAS  and  meta-­‐analysis  overview  

MGS  GWAS  

META-­‐ANALYSIS  

Genomewide  significant  associa3on  7  SNPs  on  chromosome  6p22.1  with  P<5  x  10-­‐8  

Lowest  p-­‐value  =  9.54  x  10-­‐9  

MAIN  RESULT  

MGS  Samples  

Affimetrix  6.0  GWAS  Array  No  MGS  finding  achieved  genomewide  sta(s(cal  significance  

Shi  et  al,  Nature,  09  

Page 10: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Common  variants  are  associated  with  SZ    9394  cases  /  12462  controls  

Replica3on  experiment  (50  SNPs)  underway:    Includes  AUS  dataset  

PGC  SZ  GWAS  Collabora3on,  WCPG,  Nov  09  

Page 11: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Where  is  the  culprit?  

Ioannidis  et  al,  Nat  Rev  Genet,  09  

Page 12: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

How  many  variants  do  we  expect  to  find  (e.g.  T2D)?  

18  variants  associated  with  T2D  (MAF  range:  0.073-­‐0.50;  OR:  1.05  –  1.15)  These  explain  <4%  total  liability  (small  frac(on  of  heritability):  lesson  from  GWAS  

Assuming  undiscovered  variants  have  similar  MAFs  and  ORs  to  these  18,    and    Es(ma(ng  40%  heritability,  >  800  variants  are  required    

If  assume  undiscovered  variants  are  rare,  with  MAFs  ~x10  smaller  (0.0073-­‐0.050)    and  ORs  ~10  larger  (1.63  –  4.05)  than  those  iden(fied,  ~85  variants  are  required

Frazer  et  al,  Nat  Rev  Genet,  09    

Page 13: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Large  (>3  Mb),  rare  chromosomal  dele3ons  are  associated  with  SZ  

ISC, Nature, 2008  

1q21.1:      replicates  Stefansson  et  al,  08  

15q13.3:  replicates  Stefansson  et  al,  08        CHRNA7  loca3on  

22q11.2:    overlaps  with  VCFS  dele3ons    

3391  SZ  cases/3181  ethnically  matched  controls  

Page 14: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Transethnic  mapping  

•  Pathway  &  Network  analyses  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 15: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

•  “Pure”  clinical  phenotype:  e.g.  SZ  only,  not  SA  •  Sta(s(cally  derived  symptom  dimensions  or  clusters  (factor  analysis/latent  class  analysis)  

•  Endophenotypes  (measurable  components  along  the  pathway  between  disease  [clinical  phenotype]  and  distal  genotype  [Go>esman  &  Gould,  03])  

– Neurophysiological,  neuroimaging,  neurocogni(ve  

•  Overlap  with  related  disorders  – Bipolar  Disorder  

Refining  the  SZ  phenotype  

Page 16: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Tamil  Nadu  SZ  gene3c  study  

1999:  Established  study  

2001-­‐2014:  NHMRC  Support  2001-­‐03:  family  recruitment  2003-­‐05:  linkage  2010-­‐14:  case/control    recruitment  (GWAS)  

Page 17: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Clinical  characteris3cs  of  linkage  sample  (n=262)  

Page 18: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

A  sta3s3cally  significant  linkage  result  was  observed  in  our  Indian  SZ  family  study    

Genomewide  significant  

Genomewide  sugges(ve  

Corrected  genomewide    P=0.01  

Nominal  p  =  0.01  

Nominal  p  =  0.05  

Holliday  et  al,  Am  J  Psych,  2008  

Small  sample  size:  yet  popula(on  homogeneity,  pure  SZ  phenotype,  zero  substance  abuse,  homogeneous  environment  

Page 19: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

LCA  of  606  Taiwanese  SZ  Affected  Sibling  Pairs  >1200  SZ  cases  

Holliday  et  al,  Arch  Gen  Psych,  09  

Page 20: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Chr1q23-­‐25  suscep3bility  locus  for  a  SZ  Subtype  resembling  Deficit  SZ  iden3fied  by  LCA  

Peak  LOD=3.78,  189  cM  from  p-­‐ter  (1q23-­‐25),  P=0.012;  SZ  subtype  

Original  Chr  10q  peak  using  SZ  phenotype  

Holliday  et  al,  Arch  Gen  Psych,  09  

Page 21: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Gene3c  variants  overlap  for  common  diseases  

Frazer  et  al,  Nat  Rev  Genet,  09  

Page 22: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

SZ  &  BP  partly  share  a  common  gene3c  cause  (1)    Popula(on-­‐based  Swedish  study  (>2  million  nuclear  families)  

Lichenstein  et  al,  Lancet,  09  

Page 23: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

SZ  &  BP  partly  share  a  common  gene3c  cause  (2)    Common  polygenic  varia3on    

Interna3onal  SZ  Consor3um  GWAS  (3327  cases;  3587  controls)  

•  Evaluated  whether  small  effect,  common  variants  collec(vely  account  for  a  substan(al  propor(on  of  varia(on  in  SZ  risk  

•  H1:  Increasing  propor(ons  of  small  effect  variants  will  be  detected  at  increasingly  liberal  thresholds  PT    

•  Varia(on  summarised  into  profile  scores  

•  LR  of  SZ  case-­‐control  status  on  profile  score    

•  Scores  predicted  c-­‐c  status  in  independent  samples  –  SZ,  BP,  but  not  non-­‐psych  diseases    

ISC,  Nature,  09  

Page 24: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Trans-­‐ethnic  mapping  

•  Pathway  &  Network  analyses  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 25: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Popula(ons  sampled  in  GWAS  to  date  

Rosenberg  et  al,  Nat  Rev  Genet,  2010  

No  single  popula(on  is  sufficient  for  uncovering  variants  underlying  disease  in  all  popula(ons  There  are  differences  in:  disease-­‐allele  frequency  and  LD  pa>erns  

 phenotypic  prevalence    effect  size      rare  variants  

Page 26: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

McCarthy,  Nat  Genet,  08  

Trans-­‐ethnic  mapping  will  help  iden3fy  alleles  of  cosmopolitan  effect  (e.g.  KCNQ1  in  T2D)  

KCNQ1  risk  alleles  in  East  Asians:  MAF  ~40%;  Power  to  detect  >80%    

KCNQ1  risk  alleles  in  Europeans:    MAF  ~5%;  Power  to  detect  <1%  

Trans-­‐ethnic  mapping  may  also  reveal  new  popula3on-­‐specific  loci  

Page 27: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Barreo  et  al,  Psychol  Med,  2005  

1997:  Study  commenced  

NHMRC  support:    1999-­‐2003:  recruit      sample    

 2008-­‐2010:  conduct      linkage  &  associa(on    studies  (GWAS)  

Page 28: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*
Page 29: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Iban  of  Sarawak  cluster  with  other  Asian  popula3ons:    Principal  components  analysis  of  popula3on  structure  

Xing  et  al,  Gen  Res,  2009  

Page 30: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Xing  et  al,  Gen  Res,  2009  

The  Iban  of  Sarawak  are  a  moderately  isolated  popula3on    

Page 31: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Iban  pedigree  sample  

Barreo  et  al,  05  

Pedigree  sample:  Primary  pedigree;  25  smaller  mul(plex  pedigrees;  14  pedigrees  with  demonstrated  genealogical  connec(ons  to  other  pedigrees;  85  addi(onal  pedigrees  with  proband  plus  available  1st,  2nd  degree  rela(ves  

174  individuals  with  psycho(c  disorders  (SZ,  SA,  BRP,  BP,  MDD)  

GWAS  recently  completed:  linkage  and  associa(on  analyses  underway  

Within  this  moderately  isolated  popula(on:    

Extended,  eight-­‐genera(onal  pedigree  containing  168  individuals  (23  affected)  

DNA  available  for  51  individuals  (11  affected)  

Page 32: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Transethnic  mapping  

•  Pathway  &  Network  analyses  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 33: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Pathway  Analysis  -­‐e.g.  Convergence  of  two  pathways,  DISC1  &  NRG1-­‐ErbB4  that  are  disturbed  in  SZ    

Jaaro-­‐Peled,  TINS,  09  

(a)  Neuronal  progenitor  cells:  DISC1  regulates  Wnt  Pathway;    in  nucleus,  encounters  intracell.  domains  of  NRG1  &  ErbB4  

(b)  Postmito(c  neurones  (pre/perinatally):  DISC1  interacts  with  PCM1  &  BBS  in  dynein  motor  complex  -­‐  role  in  migra(on,  arborisa(on  

(c)  Postnatal  brains:  at  PSD  of  pyram.  neurones,  together  with  NMDA-­‐type  glutamate  receptor,  DISC1  &  NRG1-­‐ErbB4  cascades  are  likely  to  converge;  may  also  converge  in  nucleus,  media(ng  gene  transcrip(on    

Page 34: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Transethnic  mapping  

•  Pathway  &  Network  analyses  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 35: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Cookson  et  al,  Nat  Rev  Genet,  09  

eQTL  and  Gene  Expression  studies  –  transcript  abundance  as  a  quan3ta3ve  trait  

Page 36: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Transethnic  mapping  

•  Pathway  analysis  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 37: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Next-­‐gen  sequencing  can  detect  rare  variants  a  component  of  gene3c  “dark  maoer”  

Antanorakis  et  al,  Nature,  2010  

Page 38: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Geographic  map  of  five    sequenced  (personal)  genomes  

Kim  et  al,  Nature,  09  

• Cost  US  $200K  with  6  week  total  run  (me  using  3  next-­‐gen  sequencers    vs  Sanger:  >$1million  

• 1000  Genomes  Project  

• Need  further  reduc(on  in:    cost  false-­‐pos,  false-­‐neg  rates    

Next-­‐genera3on  sequencing:  applica3ons  

Uses  in  human  and  model  organisms:    • Comprehensive  SNP,  CNV  and  muta3on  discovery  • Quan3fica3on  of  gene  expression    • MicroRNA  profiling  • Genomewide  methyla3on    • Protein-­‐DNA  mapping    

Page 39: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Two  NG-­‐Seq  applica3ons    

Targeted  resequencing  of  candidate  genes  

•  Resequenced  exons/splice  sites  of  10  candidate  genes  (31Kb)  for  T1D  (480  cases/480  controls)  

•  Tested  for  associa(on  in  30000  par(cipants  

•  Discovered  four  rare  variants  that  lowered  T1D  risk  independently  of  each  other  

Complete  genome  sequencing  in  families  

•  Analysed  whole  genome  sequences  of  family  of  four  (2  siblings,  both  parents)  

•  Iden(fied  recombina(on  sites  precisely  (genomic  inheritance  analysis)    

•  Iden(fied  very  rare  SNPs  •  Narrowed  the  number  of  

candidate  genes  for  both  Mendelian  disorders  in  this  family  

Nejenski  et  al,  Science,  09   Roach  et  al,  Science,  2010  

Page 40: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  Road  Ahead:  moving  from  robust  sta3s3cal  associa3ons  to  knowledge  of  causal  variants  

•  Refining  the  phenotype  •  Transethnic  mapping  

•  Pathway  analysis  •  eQTL  and  gene  expression  studies  •  Next  genera(on  sequencing  •  Func(onal  studies  

Page 41: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

The  puzzle  of  gene  deserts  e.g.  8q24  region  and  suscep3bility  to  various  cancers    

Ioannidis  et  al,  Nat  Rev  Genet,  09  335  Kb  upstream  of  closest  characterised  gene  (MYC  oncogene)  

Page 42: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

8q24  gene  desert:  further  inves3ga3ons  of  compelling  sta3s3cal  associa3on  between  rs6983267  and  Colorectal  Cancer  (CRC)  

•  Need  to  be  confident  that  finding  is  robust  –  Func(onal  studies  are  (me-­‐consuming  and  costly  

•  CRC  risk  locus  containing  rs6983267  has  in  vitro  and  in  vivo  proper(es  of  an  enhancer  and  shows  long-­‐range  physical  interac(on  with  MYC  (Using  CHiP  assays,  luciferase  reporter  assays,  chromosome  conforma(on  capture)  (Pomerantz  et  al,  Nat  Genet,  09)    

•  rs6983267  confers  poten(al  to  enhanced  Wnt  signalling  (using  CNV  analyses,  imputa(on  &  associa(on,  in  silico  methods,  transcrip(on  factor  binding  assays,  EMSA,  luciferase  reporter  assays,  CHiP-­‐Seq,  microarray  gene  expression)  (Tuupanen  et  al,  Nat  Genet,  09)  

•  In  vivo  assessment  in  model  organisms  •  Help  tremendously  to  decipher  the  basic  biological  mechanisms  

Page 43: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Celniker  et  al,  Nature,  09  

Unlocking  the  secrets  of  the  genome  

Caveat:  because  model  organisms  lack  the  genomic  variability  of  humans,  unable  to  fully  explain  human  mul(factorial  traits  

Page 44: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Clinical  transla3on  of  gene3c  findings  

McCarthy  et  al,  Nature,  08  

Page 45: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*

Acknowledgements  Perth  Carolyn  Graham  Jeremy  Hyde  

Hobart  Ken  Kirkby  Ivor  Jones  

QCMHR  Deborah  Nertney  Duncan  McLean  Elizabeth  Holliday  Patricia  Nolan  John  McGrath  Michael  Theodoros  

QBI  Vikki  Marshall  Denis  Bauer  Jake  Graoen  Heather  Smith  Cheryl  Filippich  

QIMR  Dale  Nyholt  Stuart  MacGregor  Peter  Visscher  

Iban  of  Sarawak  Robert  Barreo    Edward  Jerah  Peter  Loa  Derek  Nancarrow  

Tamil  Nadu,  India  Rangaswamy  Thara  Sujit  John  Tirupa3  Srinivasan  Giri  Krishnan  Betsy  Sajish  Ayankaran  Ramadas  Anita  Muthuraj  Sowandari  Kooeswaran    Mangala  Ramamur3    Padma  Ramachandran  Arthi  Ganesh  Meiya  Vargheese  Priya  Thirunavakarasu  Manimala  Anuradha  Vivek  Bhuvaneshwari  Anne  Lavanya  

ASRB  Vaughan  Carr  Ulrich  Schall    Rodney  Scoo  Assen  Jablensky    Patricia  Michie    Stanley  Caos  Christos  Pantelis    Frans  Henskens  

Aus  Twin  Study    Christos  Pantelis  Alex  Fornito  Jonathan  Chalk  Stephen  Rose  Dominique  Hannah  Stephen  Wood  Karen  Shaw  Liz  Leeton  Lauren  Hoiles  Carlyn  Muir  

Diaman3na  Inst,  PAH  Maohew  Brown  Patrick  Danoy  

Univ.  of  Utah    Lynn  Jorde  Scoo  Watkins  Tatum  Simonson  David  Witherspoon  

MGS  Consor3um  Pablo  Gejman  Douglas  Levinson  Alan  Sanders    Jubao  Duan  Nancy  Buccola  Robert  Freedman  Farooq  Amin  Donald  Black  Jeremy  Silverman    William  Byerley  Raymond  Crowe  C  Robert  Cloninger  Maria  Mar3nez  Brian  Suarez  

PG  SZ  Consor3um  Stephan  Ripke  

Page 46: Thechallengingrealityof schizophreniagene3cs · Howmanyvariantsdoweexpecttofind(e.g.T2D)? $ 18*variants*associated*with*T2D*(MAF*range:*0.073@0.50;*OR:*1.05*–1.15)* These*explain*